Heart transplant patients test simpler daily pill to prevent organ rejection
NCT ID NCT03373227
Summary
This study tested if a new, once-daily version of a common anti-rejection drug works as well as the standard twice-daily version for heart transplant patients. It involved 50 adults who had received a heart transplant. The main goal was to see if the simpler, once-a-day pill was just as effective at preventing the body from rejecting the new heart and if it was easier for patients to take correctly.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPLIANCE, PATIENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor University Medical Center
Dallas, Texas, 75246, United States
Conditions
Explore the condition pages connected to this study.